Olympus Corp (7733):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Olympus Corp (7733) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7444
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Olympus Corporation (Olympus) provides precision machinery and instruments. It develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, medical endoscopes and therapeutic energy devices to help healthcare professionals treat their patients; life science solutions such as laser scanning microscopes, virtual slide microscopes and disk confocal microscopes; industrial solutions like non-destructive testing (NDT) instruments, industrial microscopes, XRF and XRD analyzers, borescopes and videoscopes; and camera and audio devices like interchangeable-lens cameras, digital audio recorders, lenses and binoculars. The company and its subsidiaries operate in the Americas, Europe and Asia-Pacific. The company is headquartered in Tokyo, Japan.

Olympus Corp (7733) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Olympus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Olympus Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Olympus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Olympus Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Olympus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Olympus Corp, Medical Equipment, Deal Details 12
Asset Purchase 12
Olympus to Acquire Lithotripsy Systems from Cybersonics 12
Partnerships 13
Olympus America Enters Into Licensing Agreement With Carl Zeiss MicroImaging 13
Olympus Enters into Distribution Agreement with FlexDex 14
Olympus America Enters into Distribution Agreement with Intelligent Endoscopy 15
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 16
gMed Canada Enters into Distribution Agreement with Olympus Canada 17
Olympus Enters into Distribution Agreement with Amico 18
Terumo Enters into Distribution Agreement with Olympus Medical Systems 19
VIDA Diagnostics Expands Agreement with Olympus Respiratory America 20
Olympus Medical Enters into Distribution Agreement with Terumo Corporation 21
Terumo Expands Distribution Agreement with Olympus 22
Olympus Enters into Distribution Agreement with BrainLAB 23
Olympus and Hitachi Aloka Medical Expands Agreement 24
Sony And Olympus Form Joint Venture To Develop Surgical Endoscopes And Other Medical Devices 25
Olympus Europa Holding Enters Into Distribution Agreement With Applied Spectral Imaging For GenASIs 27
Equity Offering 28
Olympus Announces Private Placement Of Shares For US$1.17 Billion 28
Debt Offering 29
Olympus to Raise USD91 Million in Public Offering of 0.22% Bonds Due 2022 29
Asset Transactions 30
Brooklyn Hospital Center Acquires Evis Exera III From Olympus Europa 30
Acquisition 31
JPMorgan Chase to Acquire 5% Stake in Olympus from Sony for USD390 million 31
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 32
Sony Completes Acquisition Of 11.46% Stake In Olympus For US$643.7 Million 33
Olympus Corp – Key Competitors 34
Olympus Corp – Key Employees 35
Olympus Corp – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Joint Venture 40
Recent Developments 41
Strategy And Business Planning 41
Mar 07, 2018: Olympus Grand Opening of National Service Center East: Great for Region and Industry 41
Financial Announcements 42
Aug 07, 2018: Olympus: Financial results for the three months of the fiscal year ending March 31, 2019 42
Corporate Communications 44
Jul 19, 2018: Olympus names new director of medical and surgical business for the UK and Ireland 44
Government and Public Interest 45
Jan 17, 2018: Olympus TruResolution Objectives Maximize Resolution in Deep Imaging for Neuroscience Research 45
Product News 46
Sep 10, 2018: Increase efficiency and accelerate drug discovery research with NoviSight 3D Cell Analysis Software 46
Sep 03, 2018: Olympus Deep Learning Technology used to help create AI-Based pathology diagnostic tool 47
Jan 17, 2018: Olympus Launches TruResolution Objectives for Multiphoton Laser Scanning Microscopes 48
Nov 09, 2017: Olympus Launches Two Types of Upright FV3000 Confocal Laser Scanning Microscope 49
Nov 07, 2017: Launch of the SpinSR10 Super-Resolution Imaging System 50
Oct 13, 2017: Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations 51
Other Significant Developments 52
May 17, 2018: CHEST simulation center awarded $3 million in equipment donation 52
Jun 12, 2017: Image Stream Medical and Olympus introduce MedPresence, the first Virtual Medical Presence Solution for the Hospital Enterprise 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Olympus Corp, Medical Equipment, Key Facts, 2018 2
Olympus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Olympus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Olympus Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Olympus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Olympus Corp, Deals By Market, 2012 to YTD 2018 9
Olympus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Olympus to Acquire Lithotripsy Systems from Cybersonics 12
Olympus America Enters Into Licensing Agreement With Carl Zeiss MicroImaging 13
Olympus Enters into Distribution Agreement with FlexDex 14
Olympus America Enters into Distribution Agreement with Intelligent Endoscopy 15
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 16
gMed Canada Enters into Distribution Agreement with Olympus Canada 17
Olympus Enters into Distribution Agreement with Amico 18
Terumo Enters into Distribution Agreement with Olympus Medical Systems 19
VIDA Diagnostics Expands Agreement with Olympus Respiratory America 20
Olympus Medical Enters into Distribution Agreement with Terumo Corporation 21
Terumo Expands Distribution Agreement with Olympus 22
Olympus Enters into Distribution Agreement with BrainLAB 23
Olympus and Hitachi Aloka Medical Expands Agreement 24
Sony And Olympus Form Joint Venture To Develop Surgical Endoscopes And Other Medical Devices 25
Olympus Europa Holding Enters Into Distribution Agreement With Applied Spectral Imaging For GenASIs 27
Olympus Announces Private Placement Of Shares For US$1.17 Billion 28
Olympus to Raise USD91 Million in Public Offering of 0.22% Bonds Due 2022 29
Brooklyn Hospital Center Acquires Evis Exera III From Olympus Europa 30
JPMorgan Chase to Acquire 5% Stake in Olympus from Sony for USD390 million 31
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 32
Sony Completes Acquisition Of 11.46% Stake In Olympus For US$643.7 Million 33
Olympus Corp, Key Competitors 34
Olympus Corp, Key Employees 35
Olympus Corp, Other Locations 37
Olympus Corp, Subsidiaries 38
Olympus Corp, Joint Venture 40

List of Figures
Olympus Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Olympus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Olympus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Olympus Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Olympus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Olympus Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Olympus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Olympus Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Olympus Corp (7733):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Fortune Electric Co Ltd (1519):企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company provides products such as distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It …
  • International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also …
  • EnGeneIC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • AbbVie Inc (ABBV)-製薬・医療分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報
    Summary WntResearch AB (WntResearch) is a biotechnology company that develops novel anti-metastatic therapies for the treatment of cancer. The company's development stage products include Foxy-5 and Box-5. Its lead project, Foxy-5, a peptide which is in Phase I clinical development for reconstitutin …
  • True Value Company:企業の戦略・SWOT・財務情報
    True Value Company - Strategy, SWOT and Corporate Finance Report Summary True Value Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Titan Machinery Inc (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Wexford Health Sources Inc:企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Toray Industries, Inc.:企業の戦略・SWOT・財務分析
    Toray Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Toray Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Imbalie Beauty Limited:企業の戦略・SWOT・財務情報
    Imbalie Beauty Limited - Strategy, SWOT and Corporate Finance Report Summary Imbalie Beauty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Pets at Home Group Plc (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Group Plc (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kellogg Co:戦略・SWOT・企業財務分析
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Opsens Inc (OPS):医療機器:M&Aディール及び事業提携情報
    Summary Opsens Inc (Opsens), formerly DCB Capital Inc, is a provider of fiber optic sensing technology solutions. The company focuses on fractional flow reverse guidewire in interventional cardiology. It offers OptoWire, an optical-based pressure guidewire, which enhances the clinical outcome of pat …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Qu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Qu Biologics Inc (Qu Biologics) is a developer of immunotherapies designed to restore normal immune function. The company develops site specific immunomodulators that restore the body's innate immune system to treat immune-related diseases and cancer. Its site specific immunotherapy technolo …
  • San Miguel Brewery Hong Kong Ltd.
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆